drugset / Trial / NCT00005648
Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic Cancer
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to compare the effectiveness of gemcitabine with or without tipifarnib (R115777) in patients who have advanced pancreatic cancer.
Timeline
- Start
- 1999-11
- Primary completion
- —
- Completion
- 2003-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | tipifarnib | Small molecule | 200 mg | Oral |
| Background | Gemcitabine | Small molecule | 1000 mg/m2 | Intravenous |